ArticleProceedings of the National Academy of Sciences of the United States of America2025
Structural requirements of KAI2 ligands for activation of signal transduction.
Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Negative feedback regulation of karrikin signaling inProceedings of the National Academy of Sciences of the United States of America · 2026Article
- Structural and functional characterisation of a reconstructed ancestral strigolactone receptor.The Plant journal : for cell and molecular biology · 2026Article
- Molecular insights into volatile organic compound sensing and signaling in plants.The Plant journal : for cell and molecular biology · 2026Review
- Crosstalk between strigolactone and KAI2/KL signalling in plant growth and stress responses.Frontiers in plant science · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Karrikin Insensitive 2 (KAI2), identified as the receptor protein for karrikins (KARs), which are smoke-derived seed germination stimulants, belongs to the same α/β-hydrolase family as D14, the receptor for strigolactones (SLs). KAI2 is believed to recognize an endogenous butenolide (KAI2 ligand; KL), but the identity of this compound remains unknown. Recent studies have suggested that ligand hydrolysis by KAI2 is a prerequisite for receptor activation to induce interaction with the target proteins, similar to the situation with D14. However, direct experimental evidence has been lacking. Here, we designed KAI2 ligands (carba-dMGers) whose butenolide rings were modified so that they cannot be hydrolyzed or dissociated from the original ligand molecule by KAI2, by structurally modifying dMGer, a potent and selective KAI2 agonist. Using these dMGer analogs, we found that the strongly bioactive ligand, (+)-dMGer, was hydrolyzed by KAI2 at a lower enzymatic rate compared with the weakly bioactive ligand, (+)-1'-carba-dMGer, and the hydrolyzed butenolide ring of (+)-dMGer was transiently trapped in the catalytic pocket of KAI2. Additionally, structural analysis revealed that (+)-6'-carba-dMGer bound to the catalytic pocket of KAI2 in the unhydrolyzed state. However, this binding did not induce the interaction between KAI2 and SMAX1, indicating that ligand binding to the receptor alone was not sufficient for KAI2 signaling. This study showed experimental data from a ligand structure-activity study that ligand hydrolysis and subsequent covalent adduct formation with the catalytic triad plays a key role in KAI2 activation, providing insight into the chemical structure of the
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.